These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 28238787)

  • 1. Aptamer-based liposomes improve specific drug loading and release.
    Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
    J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin.
    Xing H; Li J; Xu W; Hwang K; Wu P; Yin Q; Li Z; Cheng J; Lu Y
    Chembiochem; 2016 Jun; 17(12):1111-7. PubMed ID: 27123758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
    Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
    Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active cargo loading into extracellular vesicles: Highlights the heterogeneous encapsulation behaviour.
    Chen C; Sun M; Wang J; Su L; Lin J; Yan X
    J Extracell Vesicles; 2021 Nov; 10(13):e12163. PubMed ID: 34719860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
    Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
    Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage.
    Cern A; Marcus D; Tropsha A; Barenholz Y; Goldblum A
    J Control Release; 2017 Apr; 252():18-27. PubMed ID: 28215669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes-Camouflaged Redox-Responsive Nanogels to Resolve the Dilemma between Extracellular Stability and Intracellular Drug Release.
    Ma J; Deng H; Zhao F; Deng L; Wang W; Dong A; Zhang J
    Macromol Biosci; 2018 Jul; 18(7):e1800049. PubMed ID: 29732706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Liposomal Gemcitabine with High Drug Loading Capacity.
    Tamam H; Park J; Gadalla HH; Masters AR; Abdel-Aleem JA; Abdelrahman SI; Abdelrahman AA; Lyle LT; Yeo Y
    Mol Pharm; 2019 Jul; 16(7):2858-2871. PubMed ID: 31136710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
    Haghiralsadat F; Amoabediny G; Sheikhha MH; Zandieh-Doulabi B; Naderinezhad S; Helder MN; Forouzanfar T
    Chem Biol Drug Des; 2017 Sep; 90(3):368-379. PubMed ID: 28120466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-Loaded Doxorubicin Liposomes Based on Ion-Pairing Technology with High Drug Loading and pH-Responsive Property.
    Xu H; Zhang L; Li L; Liu Y; Chao Y; Liu X; Jin Z; Chen Y; Tang X; He H; Kan Q; Cai C
    AAPS PharmSciTech; 2017 Aug; 18(6):2120-2130. PubMed ID: 28028795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug.
    Maiti K; Bhowmick S; Jain P; Zope M; Doshi K; Rajamannar T
    Anticancer Agents Med Chem; 2018; 18(4):597-609. PubMed ID: 29173186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin.
    Farasat A; Rahbarizadeh F; Ahmadvand D; Ranjbar S; Khoshtinat Nikkhoi S
    J Liposome Res; 2019 Mar; 29(1):53-65. PubMed ID: 29621912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment.
    Sathiyaseelan A; Saravanakumar K; Mariadoss AVA; Wang MH
    Carbohydr Polym; 2021 Jun; 262():117907. PubMed ID: 33838795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.